From London, Applied Clinical Trial's Editor-in-Chief Lisa Henderson provides an update on CBI's Inaugural Clinical Trial Registries and Results Databases conference.
While a record-breaking snowfall in London made travel difficult for speakers and attendees alike, the "show went on" for the Center for Business Intelligence's Inaugural Clinical Trial Registries and Results Databases conference held for the first time outside the United States.
The attendees-largely of course from Europe-came to learn more about the international registry requirements for clinical trials, as well as the newly-implemented clinical trials results requirements on clinicaltrials.gov. FDAAA's requirement called for the trial results implementation at the end of September 2008. We last reported on the topic in October. See, www.appliedclinicaltrialsonline.com/FDAAA
As was evident, pharma and government alike are struggling with these new transparency initiatives. While no one is against transparency in clinical trials, a number of issues regarding data, analysis, various stakeholders, ethics and more came to light during the conference. Nicholas Ide, chief architect of ClinicalTrials.gov said updated the attendees on the challenges they have had regarding information and data submitted to clinicaltrials.gov results. Of 250-plus results submitted, approximately 46 have been published to the Web site. The others? Sent back to sponsors with comments and questions. A spring meeting has not yet been formally scheduled to update the next steps in the clinicaltrials.gov clinical trials results reporting database.
Kevin Palmaccio, conference producer, noted that conference went very well, despite the weather challenges. "We made a lot of accomplishments here and a lot of good discussion with various stakeholders. More still needs to be done, but there is good momentum."
CBI's 4th Forum on Clinical Trials Registries and Results Databases will be held in Vienna, VA, April 21-22, where hopefully those new updates from clinicaltrials.gov will be available. Even so, the need for European-based information is clearly necessary. Palmaccio said that the organization will definitely hold a second event in Europe next year.
Editor's Note: A news article from this conference will appear in March. Also, CBI is an Advanstar Communications company, which is also the parent company of Applied Clinical Trials.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
MariTide Shows Up to 20% Weight Loss in Phase II Trial for Obesity, Type 2 Diabetes
June 24th 2025In a Phase II trial, Amgen’s investigational therapy MariTide (maridebart cafraglutide) delivered significant, sustained weight loss of up to 20% in adults with obesity, with or without type 2 diabetes, alongside notable improvements in glycemic control, supporting its advancement to Phase III studies as a potential once-monthly treatment option.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.